news
Home treatment trumps hospital
Cultural change needed to expand healthcare in the home, forum says.
Some health professionals in the acute sector may be apprehensive when it comes to releasing patients into the healthcare in the home system, but it may be the best move for the patient.
This was a key point raised by speakers at Taking Healthcare Home, the recent forum of the Australian Centre for Health Services Innovation( AusHSI).
To inform debate at the forum, the centre
produced an issues paper of the same name that compared hospital treatment with acute and chronic treatment services in the home.
The paper found that, in many cases, it was better for the patient and more cost effective to provide treatment at home than in hospital, and that cultural change in the health profession was needed to overcome uncertainty about quality and safety.
Forum speaker Melissa McCusker, the nurse unit manager responsible for the Acute Care @ Home services of QEII Hospital in Brisbane, said home treatment was not a new concept but could be difficult for patients and staff to understand.
“ There needs to be a good working relationship and trust among the whole healthcare team,” McCusker said.“ Besides the cost savings, patients often prefer being at home, and there can be other benefits like a reduced risk of hospital acquired / cross infection, medication errors and decreased patient depression and anxiety.”
AusHSI academic director professor Nick Graves said healthcare in the home was a priority for the government because of its potential to improve patient flow, meet national emergency access targets and increase capacity within the healthcare system.
Graves added:“ When you are in hospital, there are more opportunities for complex, costly and often unnecessary investigations and treatments to happen.” ■
Stay up to date with the 2017 aMh Book or online
AMH 2017 includes up-to-date drug information to help you stay informed in your profession. Every edition has hundreds of amendments, updates and additions to reflect the latest shifts in evidence and practice.
More than 20 new drugs have been added to the latest edition, including Ulipristal for emergency contraception, Idarucizumab for reversal of dabigatran anticoagulation and Paritaprevir with ritonavir, ombitasvir and dasabuvir for chronic hepatitis C.
Therapeutic topics have been reviewed and updated, eg Dyslipidaemia now includes evolocumab and a table comparing lipidlowering drugs.
There is also new safety information, eg severe skin reactions with bromhexine.
New to AMH online is a drug interactions search capability, for interactions between drug / drug or drug / class pairs.
To find out more, go to www. amh. net. au optiMiSe Care to the elderly with the aMh aGed Care CoMpanion
The AMH Aged Care Companion is a trusted, practical reference for doctors, nurses and pharmacists who work with older people. It contains the latest evidence-based information and is useful when conducting medication reviews and other activities( eg case conferencing) aimed at improving patient outcomes.
Latest edition changes include:
• a new topic on actinic keratosis
• information on the process of deprescribing- important for optimising the use of medicines in older people
• new illustrated inhaler device guide with links to instructions for choosing inhalers suitable for older patients
Other topics reviewed include asthma, COPD, gout, hypertension, dyslipidaemia and dyspepsia.
Available in print or online.
agedcareinsite. com. au 7